Obesity-Induced Cellular Senescence Drives Anxiety and Impairs Neurogenesis

Mikolaj Ogrodnik,Yi Zhu,Larissa G P Langhi,Tamar Tchkonia,Patrick Krüger,Edward Fielder,Stella Victorelli,Rifqha A Ruswhandi,Nino Giorgadze,Tamar Pirtskhalava,Oleg Podgorni,Grigori Enikolopov,Kurt O Johnson,Ming Xu,Christine Inman,Allyson K Palmer,Marissa Schafer,Moritz Weigl,Yuji Ikeno,Terry C Burns,João F Passos,Thomas von Zglinicki,James L Kirkland,Diana Jurk
DOI: https://doi.org/10.1016/j.cmet.2018.12.008
2019-05-07
Abstract:Cellular senescence entails a stable cell-cycle arrest and a pro-inflammatory secretory phenotype, which contributes to aging and age-related diseases. Obesity is associated with increased senescent cell burden and neuropsychiatric disorders, including anxiety and depression. To investigate the role of senescence in obesity-related neuropsychiatric dysfunction, we used the INK-ATTAC mouse model, from which p16Ink4a-expressing senescent cells can be eliminated, and senolytic drugs dasatinib and quercetin. We found that obesity results in the accumulation of senescent glial cells in proximity to the lateral ventricle, a region in which adult neurogenesis occurs. Furthermore, senescent glial cells exhibit excessive fat deposits, a phenotype we termed "accumulation of lipids in senescence." Clearing senescent cells from high fat-fed or leptin receptor-deficient obese mice restored neurogenesis and alleviated anxiety-related behavior. Our study provides proof-of-concept evidence that senescent cells are major contributors to obesity-induced anxiety and that senolytics are a potential new therapeutic avenue for treating neuropsychiatric disorders.
What problem does this paper attempt to address?